Polyclinique Saint-Come
- Address
- 7 Rue Jean Jacques Bernard, 60200 Compiègne, France
Polyclinique Saint-Come - Oncology Research Center
Polyclinique Saint-Come is a specialized clinical research facility with a strong focus on oncology clinical trials, particularly in gastrointestinal and breast cancers. The center demonstrates expertise in evaluating novel targeted therapies, immunotherapies, and personalized treatment approaches across various cancer types.
- Advanced colorectal cancer research, including KRAS-mutated and metastatic disease with innovative combination therapies
- Breast cancer studies focusing on HER2-positive and triple-negative breast cancer with treatment de-escalation strategies
- Gastrointestinal malignancies including ampullary adenocarcinoma and metastatic oeso-gastric cancer
- Precision oncology trials utilizing biomarker-driven approaches and FGFR-targeted therapies
The center actively participates in Phase II and Phase III multicenter trials, contributing to advancement in cancer treatment optimization. Research efforts include evaluating combination regimens with targeted agents such as pembrolizumab, fruquintinib, and pemigatinib, as well as investigating therapeutic de-escalation in patients achieving favorable responses. Additionally, Polyclinique Saint-Come participates in cardiovascular research, including studies on atherosclerotic cardiovascular disease in end-stage kidney disease patients undergoing dialysis, demonstrating a commitment to addressing complex medical conditions beyond oncology.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 33 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Polyclinique Saint-Come
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects with End Stage Kidney Disease Undergoing Dialysis | CSL Behring LLC | Phase IV | Recruiting | Jul 2023 | — |
IMP list
lock Showing 1 of 33 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fluorouracil | 4 | Unknown | 2024-07-30 | 2026-02-19 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.